Mackay Shields LLC’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-173,561
Closed -$1.89M 690
2022
Q1
$1.89M Sell
173,561
-7,215
-4% -$95.1K 0.02% 569
2021
Q4
$2.45M Sell
180,776
-4,304
-2% -$57.5K 0.02% 530
2021
Q3
$2.51M Sell
185,080
-5,350
-3% -$75.9K 0.02% 496
2021
Q2
$2.72M Sell
190,430
-15,516
-8% -$224K 0.03% 483
2021
Q1
$2.88M Buy
205,946
+3,833
+2% +$62.5K 0.02% 616
2020
Q4
$3.79M Buy
+202,113
New +$3.3M 0.03% 576

Other funds holding VTRS

Mackay Shields LLC's VTRS Position: Q2 2022 in Review

Mackay Shields LLC sold out of Viatris (VTRS) in Q2 2022, closing a stake of 173,561 shares — an estimated $1.89M sold.

Mackay Shields LLC first reported a position in VTRS in Q4 2020 and held it in 6 quarters. The position peaked at $3.79M in Q4 2020. 1,010 funds tracked by Wall St. Rank hold VTRS as of Q2 2022.

  • Mackay Shields LLC reported no remaining Viatris position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 173,561 Viatris shares in Q2 2022, an estimated $1.89M.
  • Mackay Shields LLC first reported a position in Viatris in Q4 2020 and held it in 6 quarters.
  • Mackay Shields LLC's Viatris position peaked at $3.79M in Q4 2020.
  • 1,010 funds tracked by Wall St. Rank held Viatris as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.